1. Background
2. Methods
2.1. Trial Design and Population
2.2. Randomization and Blinding
2.3. Outcomes
2.4. Sample Size
2.5. Ethical Considerations
2.6. Statistical Methods
3. Results
| Variable | Intervention | Control | P Value |
|---|---|---|---|
| Age, y | 48.8 ± 9.75 | 45.84 ± 12.08 | > 0.22 |
| Gender | |||
| Female | 10 (40) | 12 (48) | > 0.32 |
| Male | 15 (60) | 13 (52) | > 0.58 |
aValues are expressed as mean ± SD or No. (%).
| Variables | Intervention | Control | P Value |
|---|---|---|---|
| Pain levels | 6.36 ± 0.181 | 7.68 ± 0.15 | < 0.001 |
| Transient fever | 5 (20) | 2 (8) | < 0.05 |
| Blood loss | 0.33 ± 0.09 | 0.37 ± 0.11 | > 0.78 |
| Urine leakage | |||
| G2 | 21 (84) | 23 (92) | > 0.9 |
| G3 | 4 (16) | 2 (8) | < 0.002 |
| Hospital stay, h | 47.04 ± 2.585 | 55.68 ± 2.673 | < 0.02 |
| Transfusion | 1 (4) | 3 (12) | > 0.6 |
| Analgesic requirements (Pethidine) | 212 ± 11.28 | 296 ± 21 | < 0.001 |
| Satisfactory | 7.68 ± 0.18 | 6.36 ± 0.21 | < 0.001 |
aValues are expressed as mean ± SD or No. (%).
